The Organic Chemistry of Drug Synthesis, Volume 5

(11)
The Organic Chemistry of Drug Synthesis, Volume 5 image
ISBN-10:

0471589594

ISBN-13:

9780471589594

Author(s): Lednicer, Daniel
Edition: 1
Released: Nov 07, 1994
Format: Hardcover, 240 pages

Description:

Updated every five years, the series represents the optimal compromise between currency and a sufficient body of material for cohesive and comprehensive treatment in a monograph. Provides a quick yet thorough overview of the synthetic routines that have been used to access specific classes of therapeutic agents. Materials are organized by chemical class, and syntheses are taken back to available starting materials. Discusses disease state, rational for method of drug therapy, biological activities of each compound and preparation. Coverage also includes those generic pharmaceutical compounds not accorded clinical status. A glossary defines biological terms.

Best prices to buy, sell, or rent ISBN 9780471589594




Related Books

Frequently Asked Questions about The Organic Chemistry of Drug Synthesis, Volume 5

You can buy the The Organic Chemistry of Drug Synthesis, Volume 5 book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $10.99 on Amazon and is available from 12 sellers at the moment.

If you’re interested in selling back the The Organic Chemistry of Drug Synthesis, Volume 5 book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the The Organic Chemistry of Drug Synthesis, Volume 5 book, the best buyback offer comes from and is $ for the book in good condition.

The The Organic Chemistry of Drug Synthesis, Volume 5 book is in very low demand now as the rank for the book is 11,952,350 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.